Updates are available Correction dated 2024-06-22
Click to view Correction: https://doi.org/10.1186/s13046-024-03102-y
-
Authors
Atwani, Rula
Nagare, Rohit Pravin
Rogers, Amber
Prasad, Mayuri
Lazar, Virginie
Sandusky, George
Tong, Yan
Pin, Fabrizio
Condello, Salvatore
- License Information
-
More Information
Article History
Received: 12 February 2024
Accepted: 27 May 2024
First Online: 1 June 2024
Change Date: 22 June 2024
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1186/s13046-024-03102-y
Declarations
:
: De-identified malignant ascites fluid specimens from OC patients were obtained at the Indiana University Simon Comprehensive Cancer Center (IUSCCC) under an IRB approved protocol (HRPP #1905951308). The study was conducted in accordance with the International Ethical Guidelines for Biomedical Research Involving Human Subjects and represented minimal risk to subjects. The studies in this work abide by the Declaration of Helsinki principles. All animal studies were approved by the Institutional Animal Care and Use Committee at Indiana University School of Medicine and were in compliance with the The Animal Care and Use Review Office of the USAMRDC Office of Research Protections (ORP).
: All authors have read and approved the manuscript for its publication.
: M. P. is currently working as a research fellow at Labcorp Drug Development. The authors declare that they have no conflicts of interest with the contents of this article.
